Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

ADMA Biologics Inc. (ADMA) (ADMA)

3.09   0.5 (19.31%) 04-03 16:00
Open: 2.58 Pre. Close: 2.59
High: 3.12 Low: 2.51
Volume: 4,635,233 Market Cap: 267M
ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.124 - 3.137 3.137 - 3.149
Low: 2.484 - 2.496 2.496 - 2.507
Close: 3.068 - 3.09 3.09 - 3.11

Technical analysis

as of: 2020-04-03 4:34:32 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 4.32     One year: 5.05
Support: Support1: 2.31    Support2: 1.45
Resistance: Resistance1: 3.70    Resistance2: 4.32
Pivot: 2.58
Moving Average: MA(5): 2.78     MA(20): 2.53
MA(100): 3.71     MA(250): 4.07
MACD: MACD(12,26): -0.06     Signal(9): -0.15
Stochastic oscillator: %K(14,3): 61.93     %D(3): 61.17
RSI: RSI(14): 54.29
52-week: High: 5.48  Low: 1.45  Change(%): -39.9
Average Vol(K): 3-Month: 254226  10-Days: 407614

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ADMA has closed below upper band by 24.8%. Bollinger Bands are 73.1% wider than normal. The large width of the bands suggest high volatility as compared to ADMA's normal range. The bands have been in this wide range for 19 bars. This is a sign that the current trend might continue.

Headline News

Tue, 24 Mar 2020
AYTU To Distribute COVID-19 Tests, MIST Flops, HOTH Sets Eyes On Virus Vaccine

Tue, 11 Feb 2020
Tuesday 2/11 Insider Buying Report: CFR, ADMA

Thu, 22 Aug 2019
Health Care Sector Update for 08/22/2019: CLSD, RTRX, ADMA, JNJ, PFE, ABT, MRK, AMGN

Tue, 02 Apr 2019
Health Care Sector Update for 04/02/2019: ADMA, EVOK, ANGO, JNJ, PFE, ABT, MRK, AMGN

Tue, 02 Apr 2019
Health Care Sector Update for 04/02/2019: RUBY,ADMA,EVOK

Tue, 02 Apr 2019
Health Care Sector Update for 04/02/2019: IMAC,RUBY,ADMA,EVOK

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 86.35
Shares Float (M) 64.09
% Held by Insiders 7.35
% Held by Institutions 43.86
Shares Short (K) 5360
Shares Short P. Month (K) 4650

Stock Financials

EPS -0.888
Book Value (p.s.) 0.440
PEG Ratio
Profit Margin -164.50
Operating Margin -141.14
Return on Assets (ttm) -24.0
Return on Equity (ttm) -210.1
Qtrly Rev. Growth 196.7
Gross Profit (p.s.) -0.118
Sales Per Share 0.340
EBITDA (p.s.) -0.442
Qtrly Earnings Growth
Operating Cash Flow (M) -76.19
Levered Free Cash Flow (M) -61.32

Stock Valuations

P/E -3.48
P/E Growth Ratio 0.19
P/BV 7.02
P/CF -3.50

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.